Crescent Capital BDC Files 8-K for Regulation FD Disclosure
Ticker: FCRX · Form: 8-K · Filed: Jun 11, 2024 · CIK: 1633336
| Field | Detail |
|---|---|
| Company | Crescent Capital Bdc, Inc. (FCRX) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
Related Tickers: CCAP
TL;DR
CCAP filed an 8-K for a Reg FD disclosure on 6/11/24.
AI Summary
On June 11, 2024, Crescent Capital BDC, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure, indicating a need to disseminate material information to the public. No specific financial transactions or material events beyond the disclosure itself are detailed in the provided text.
Why It Matters
This filing ensures that Crescent Capital BDC, Inc. is complying with disclosure regulations, providing timely and fair information to all investors.
Risk Assessment
Risk Level: low — The filing is a standard regulatory disclosure and does not contain information about significant financial events or risks.
Key Players & Entities
- Crescent Capital BDC, Inc. (company) — Registrant
- June 11, 2024 (date) — Date of Report
- Regulation FD (regulation) — Disclosure Item
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to provide a Regulation FD Disclosure.
What is the exact name of the registrant?
The exact name of the registrant is Crescent Capital BDC, Inc.
On what date was this report filed?
The report was filed on June 11, 2024.
In which state is Crescent Capital BDC, Inc. incorporated?
Crescent Capital BDC, Inc. is incorporated in Maryland.
What is the principal executive office address of Crescent Capital BDC, Inc.?
The principal executive office address is 11100 Santa Monica Blvd., Suite 2000, Los Angeles, CA 90025.
Filing Stats: 555 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-06-11 06:30:34
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share CCAP The Nasdaq
Filing Documents
- d850775d8k.htm (8-K) — 25KB
- 0001193125-24-158700.txt ( ) — 184KB
- fcrx-20240611.xsd (EX-101.SCH) — 4KB
- fcrx-20240611_def.xml (EX-101.DEF) — 14KB
- fcrx-20240611_lab.xml (EX-101.LAB) — 23KB
- fcrx-20240611_pre.xml (EX-101.PRE) — 15KB
- d850775d8k_htm.xml (XML) — 6KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 11, 2024 Crescent Capital BDC, Inc. (Exact name of registrant as specified in its charter) Maryland 814-01132 47-3162282 (State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (I.R.S. Employer Identification No.) 11100 Santa Monica Blvd. , Suite 2000 , Los Angeles , CA 90025 (Address of Principal Executive Offices) (Zip Code) Registrant's Telephone Number, Including Area Code: (310) 235-5900 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to 12(b) of the Act: Securities registered pursuant to Section 12(g) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.001 par value per share CCAP The Nasdaq Stock Market LLC 5.00% Notes due 2026 FCRX The New York Stock Exchange Common Stock, par value $0.001 per share (Title of class) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item7.01. Regulation FD Disclosure. Crescent Capital BDC, Inc. (the "Company") (NASDAQ: CCAP) is hosting its previously announced Analyst & Investor Day on Tuesday, June 11, 2024 via a live video stream starting at 6:00 p.m. (Eastern Time). The Company is posting the presentation that will be used during the Analyst & Investor Day on the Events & Presentations section of its website at www.crescentbdc.com . For time to time, the Company uses its website as a distribution channel for financial and other important information. Information on the Company's website is not incorporated by reference herein and is not a part of this Form 8-K. The information disclosed under this Item 7.01 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. CRESCENT CAPITAL BDC, INC. Date: June 11, 2024 By: /s/ Gerhard Lombard Name: Gerhard Lombard Title: Chief Financial Officer